Abstract:Background: Circulatory shock, defined as decreased tissue perfusion, leading to inadequate oxygen delivery to meet cellular metabolic demands, remains a common condition with high morbidity and mortality. Rapid restitution and restoration of adequate tissue perfusion are the main treatment goals. To achieve this, current hemodynamic strategies focus on adjusting global physiological variables such as cardiac output (CO), hemoglobin (Hb) concentration, and arterial hemoglobin oxygen saturation (SaO2). However, it remains a challenge to identify optimal targets for these global variables that best support microcirculatory function. Weighting up the risks and benefits is especially difficult for choosing the amount of oxygen supplementation in critically ill patients. This review assesses the physiological basis for oxygen delivery to the tissue and provides an overview of the relevant literature to emphasize the importance of considering risks and benefits and support decision making at the bedside. Physiological premises: Oxygen must reach the tissue to enable oxidative phosphorylation. The human body timely detects hypoxia via different mechanisms aiming to maintain adequate tissue oxygenation. In contrast to the pulmonary circulation, where the main response to hypoxia is arteriolar vasoconstriction, the regulatory mechanisms of the systemic circulation aim to optimize oxygen availability in the tissues. This is achieved by increasing the capillary density in the microcirculation and the capillary hematocrit thereby increasing the capacity of oxygen diffusion from the red blood cells to the tissue. Hyperoxia, on the other hand, is associated with oxygen radical production, promoting cell death. Current state of research: Clinical trials in critically ill patients have primarily focused on comparing macrocirculatory endpoints and outcomes based on stroke volume and oxygenation targets. Some earlier studies have indicated potential benefits of conservative oxygenation. Recent trials show contradictory results regarding mortality, organ dysfunction, and ventilatory-free days. Empirical studies comparing various targets for SaO2, or partial pressure of oxygen indicate a U-shaped curve balancing positive and negative effects of oxygen supplementation. Conclusion and future directions: To optimize risk-benefit ratio of resuscitation measures in critically ill patients with circulatory shock in addition to individual targets for CO and Hb concentration, a primary aim should be to restore tissue perfusion and avoid hyperoxia. In the future, an individualized approach with microcirculatory targets will become increasingly relevant. Further studies are needed to define optimal targets.

Pathophysiology of circulatory shock: an overview

Temporary circulatory support for cardiogenic shock

Hemorrhagic Shock and the Microvasculature

Evaluation of Vasoactive Agents on Microcirculatory Disturbance in Shock Patients

Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality

Ion Channels Remodeling in the Regulation of Vascular Hyporesponsiveness During Shock

Science and shock: a clinical perspective

Cerebral Hemodynamic and Metabolic Alterations in Hypovolemic Shock

Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock

Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy

Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors

Common Hemodynamic Classification of Circulatory Failure and Therapy Principles

Angiotensin Ii In The Treatment Of Distributive Shock: A Systematic-Review And Meta-Analysis

Haemodynamic Resuscitation Following Traumatic Haemorrhagic Shock: An Overview

Rapid treatment of shock

Gastrointestinal complications in shock

Vasoactive pharmacologic therapy in cardiogenic shock: a critical review

Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage

[Acute heart failure and cardiogenic shock: pathophysiology, clinical aspects and management strategies]

The physiological basis for individualized oxygenation targets in critically ill patients with circulatory shock

A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock